Suboptimal Medical Therapy After Coronary Revascularization
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference13 articles.
1. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association;Kulik;Circulation,2015
2. Secondary prevention after coronary artery bypass graft surgery: a primer;Kulik;Curr Opin Cardiol,2016
3. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the Clopidogrel After Surgery For Coronary Artery Disease (CASCADE) trial;Kulik;Circulation,2010
4. Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits?;Kulik;Curr Opin Cardiol,2011
5. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association;Fleg;Circulation,2013
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Algorithms of Perioperative Management of High-Risk Cardiac Surgery Patients with Coronary Artery Disease and Polymorbidity;Ukrainian Journal of Cardiovascular Surgery;2023-03-27
2. A New Effect Modifier of the Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention Decision: Physical and Mental Functioning;Circulation;2022-10-25
3. Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3′,4,5′-Tetramethoxystilbene;Pharmaceutics;2022-09-26
4. The American Association for Thoracic Surgery and The Society of Thoracic Surgeons reasoning for not endorsing the 2021 ACC/AHA/SCAI Coronary Revascularization Guidelines;The Journal of Thoracic and Cardiovascular Surgery;2021-12
5. The American Association for Thoracic Surgery and Society of Thoracic Surgeons Reasoning for Not Endorsing the 2021 ACC/AHA/SCAI Coronary Revascularization Guidelines;The Annals of Thoracic Surgery;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3